The must read stories and talking points from Tuesday

Google game changer

The NHS has deepened its relationship with Google after Royal Free London Foundation Trust announced the most significant deal to date between the health service and the tech giant’s artificial intelligence arm, DeepMind.

The trust’s five year “developmental” deal with DeepMind extends an existing partnership, which was already one of the NHS’s most closely watched digital projects.

Trust chief executive David Sloman told us the app it is developing will be a “game changer”. It will track real time patient data and alert clinicians “within seconds rather than hours” when patient tests show signs of serious illness, he said. “All our patients will benefit from it. Doctors and nurses currently spend far too much time on paperwork, and we believe this technology could substantially reduce this burden, enabling doctors and nurses to spend more time on what they do best – treating patients.”

Neither the Royal Free nor DeepMind would disclose the financial arrangements of the deal because of “commercial sensitivity”. HSJ understands the costs for the NHS will be relatively low in the development phase. The company will aim for significant financial gains, but in the longer term.

Earlier this year concerns were raised by the media and campaigners about the level of access DeepMind had to patient records, after New Scientist obtained a copy of a data sharing agreement between the company and the trust.

While the trust maintains information processed by the app was for the “purpose of patient care only” and it would “remain the data controller at all times”, there is acceptance that this is a key issue.

Naylor’s wisdom

Sir Robert Naylor is leaving the NHS after 16 years as chief executive University College London Hospitals Foundation Trust, where he has been one of the most highly regarded leaders in the health service.

On we publish a version of his retirement speech, in which he speaks about the next chapter of his career and what it takes to be a CEO in the NHS.